N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide

C81H89F12N19O8 — CID 164982892

IUPACN-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide
SMILESCc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1C.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@H]2c2ccc(C(F)(F)F)nc2)cnc1N
InChIInChI=1S/C21H23F3N4O2.3C20H22F3N5O2/c1-12-4-6-17(15-5-7-18(26-9-15)21(22,23)24)28(11-12)20(30)19(29)27-16-8-13(2)14(3)25-10-16;3*1-11-3-5-15(13-4-6-16(25-8-13)20(21,22)23)28(10-11)19(30)18(29)27-14-7-12(2)17(24)26-9-14/h5,7-10,12,17H,4,6,11H2,1-3H3,(H,27,29);3*4,6-9,11,15H,3,5,10H2,1-2H3,(H2,24,26)(H,27,29)/t;2*11-,15+;/m.10./s1
InChIKeyFSZYDQTXUFLRKP-IKCNRDEVSA-N
MW1684.70 g/mol
LogP14.02
Rot. Bonds8

About N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide

N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide (PubChem CID 164982892) has the molecular formula C81H89F12N19O8 and a molecular weight of 1684.70 g/mol. Its IUPAC name is N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide.

Molecular Properties

Compound NameN-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide
PubChem CID164982892
Molecular FormulaC81H89F12N19O8
Molecular Weight1684.70 g/mol
Exact Mass1683.69
IUPAC NameN-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide
SMILESCc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1C.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@H]2c2ccc(C(F)(F)F)nc2)cnc1N
InChIInChI=1S/C21H23F3N4O2.3C20H22F3N5O2/c1-12-4-6-17(15-5-7-18(26-9-15)21(22,23)24)28(11-12)20(30)19(29)27-16-8-13(2)14(3)25-10-16;3*1-11-3-5-15(13-4-6-16(25-8-13)20(21,22)23)28(10-11)19(30)18(29)27-14-7-12(2)17(24)26-9-14/h5,7-10,12,17H,4,6,11H2,1-3H3,(H,27,29);3*4,6-9,11,15H,3,5,10H2,1-2H3,(H2,24,26)(H,27,29)/t;2*11-,15+;/m.10./s1
InChIKeyFSZYDQTXUFLRKP-IKCNRDEVSA-N
XLogP14.02
TPSA378.82 Ų
H-Bond Donors7
H-Bond Acceptors19
Rotatable Bonds8
Heavy Atoms120
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001684.70
LogP ≤ 514.02
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide?
The IUPAC name of N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide (CID 164982892) is N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide.
What is the SMILES notation for N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide?
The canonical SMILES for N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide is Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1C.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2c2ccc(C(F)(F)F)nc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@H]2c2ccc(C(F)(F)F)nc2)cnc1N.
What is the InChIKey of N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide?
The InChIKey is FSZYDQTXUFLRKP-IKCNRDEVSA-N. The full InChI is InChI=1S/C21H23F3N4O2.3C20H22F3N5O2/c1-12-4-6-17(15-5-7-18(26-9-15)21(22,23)24)28(11-12)20(30)19(29)27-16-8-13(2)14(3)25-10-16;3*1-11-3-5-15(13-4-6-16(25-8-13)20(21,22)23)28(10-11)19(30)18(29)27-14-7-12(2)17(24)26-9-14/h5,7-10,12,17H,4,6,11H2,1-3H3,(H,27,29);3*4,6-9,11,15H,3,5,10H2,1-2H3,(H2,24,26)(H,27,29)/t;2*11-,15+;/m.10./s1.
What are the key properties of N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide?
N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide has a molecular weight of 1684.70 g/mol, XLogP of 14.02, 8 rotatable bonds, 7 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide;N-(5,6-dimethyl-3-pyridinyl)-2-[5-methyl-2-[6-(trifluoromethyl)-3-pyridinyl]piperidin-1-yl]-2-oxoacetamide is sourced from PubChem (CID 164982892), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).